Aspartate aminotransferase‐to‐platelet ratio index outperforms Fibrosis‐4 in 2843 Korean patients with metabolic dysfunction‐associated steatotic liver disease
The APRI was the most effective noninvasive fibrosis marker across NAFLD, MAFLD, and MASLD, particularly in age-stratified analyses. Further research is needed to establish standardized cut-off values and enhance the clinical utility of these markers in managing liver fibrosis.
Authors
- Won Young Tak (ORCID: https://orcid.org/0000-0002-1914-5141)
- Ki Tae Yoon (ORCID: https://orcid.org/0000-0002-8580-0239)
- Se Young Jang (ORCID: https://orcid.org/0000-0001-9148-9670)
- Yang Hyun Baek (ORCID: https://orcid.org/0000-0002-9073-9233)
- Dae Won Jun (ORCID: https://orcid.org/0000-0002-2875-6139)
- Sang Yi Moon (ORCID: https://orcid.org/0000-0002-8929-9250)
- Yu Rim Lee (ORCID: https://orcid.org/0000-0003-1916-1448)
- Young Oh Kweon (ORCID: https://orcid.org/0000-0001-5708-7985)
- Aejeong Jo (ORCID: https://orcid.org/0000-0003-1228-7021)
- Young Youn Cho (ORCID: https://orcid.org/0000-0002-9384-5357)
- Soo Young Park (ORCID: https://orcid.org/0000-0002-4944-4396)
- Hoon Gil Jo (ORCID: https://orcid.org/0000-0002-0947-7185)
Institutions
- Gyeongguk National University (KR)
- Kyungpook National University Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- Chung-Ang University Hospital (KR)
- Hanyang University (KR)
- Pusan National University (KR)
- Dong-A University (KR)
- Wonkwang University (KR)
Publication Details
- Journal
- Hepatology Research
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1111/hepr.14143
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16